Page last updated: 2024-08-25

rosiglitazone and Adenomatous Polyposis Coli

rosiglitazone has been researched along with Adenomatous Polyposis Coli in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seed, B1

Other Studies

2 other study(ies) available for rosiglitazone and Adenomatous Polyposis Coli

ArticleYear
PPAR--the good news and the bad.
    Nature medicine, 1998, Volume: 4, Issue:9

    Topics: Adenomatous Polyposis Coli; Animals; Chromans; Humans; Hypoglycemic Agents; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

1998
PPARgamma and colorectal carcinoma: conflicts in a nuclear family.
    Nature medicine, 1998, Volume: 4, Issue:9

    Topics: Adenomatous Polyposis Coli; Animals; Chromans; Colorectal Neoplasms; Humans; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone

1998